Oral: Liberum raises its course goal

Liberum relies on its 'keep' tips. Oral and raises its target price by 216,250 euros, forecasting for the cosmetic glove organic sales growth of 5.7% during 2019-23, slightly above the long-term average

In 2019, the broker expects Oral & # 39; to exceed total market growth of 5.5%, driven by innovation, a robust year in luxury, and strong growth in skin care & # 39;

"Strong cash flow supports our expectation of increasing payout dividends and smart acquisitions," adds Liberum, who models an annual buyout program with 750 million euros.

Copyright (c) 2019 CercleFinance.com. All rights reserved.
The information and analysis disseminated by Cercle Finance is only an aid to the decision for investors. Cercle Finance's liability cannot be retained directly or indirectly after the readers' use of the information and analysis. It is recommended that every uninformed person consult a professional advisor before investing. This information does not constitute an invitation to sell or a request to buy.